Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05452902
Status:
RECRUITING
Last Update Posted:
2023-12-07
First Post:
2022-07-06
Brief Title:
Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
The Effects of Exercise and Nutrition Interventions on Platinum Chemotherapy-induced Peripheral Neuropathy and Interoceptive Brain Circuitry R21
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Chemotherapy-induced peripheral neuropathy CIPN is a highly prevalent and severe side-effect of platinum-based chemotherapy often used to treat gastrointestinal cancers Unfortunately there are very limited treatments for CIPN This is a phase II randomized controlled trial to test the preliminary efficacy of exercise vs nutrition education on CIPN to systematically investigate the potential roles of inflammation and interoception and to obtain data with a more accurate effect size to inform a future study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R21CA259422 | NIH | None | httpsreporternihgovquickSearchR21CA259422 |